biostudies-literatureFukuhara SNational Research Service AwardMedtronic IncNational Heart, Lung, and Blood InstituteNHLBI NIH HHSNational Institutes of HealthPhil Jenkins and Darlene &amp; Stephen J. Szatmari Funds539-547.e1https://www.ebi.ac.uk/biostudies/studies/S-EPMC7388726biostudies-literatureUnknown162(2)<h4>Objective</h4>Despite the rapid adoption of transcatheter aortic valve replacement (TAVR) and worldwide interest in its implantation, TAVR valve explantation has not been well described.<h4>Methods</h4>We retrospectively reviewed 1442 consecutive patients who underwent a TAVR procedure between 2011 and 2019, in which TAVR explantation was performed in 15 patients (1.0%). In addition, 2 patients from outside institutions also underwent TAVR explantation at our institution. We reviewed the clinical details of these 17 patients.<h4>Results</h4>The frequency of TAVR explant increased over time from 0 to 1 during the period from 2011 to 2015 to 6 in 2019. The mean age was 73.0 ± 9.3 years. The majority of patients (88.2%) were in New York Heart Association functional class IV heart failure.The Journal of thoracic and cardiovascular surgerySurgical explantation of transcatheter aortic bioprostheses: Results and clinical implications.PMC7388726T32 HL0761235T32HL076123Fukuhara SDeeb GMKim KMRosati CMYang BBrescia AAShiomi SfalseSurgical explantation of transcatheter aortic bioprostheses: Results and clinical implications.<h4>Objective</h4>Despite the rapid adoption of transcatheter aortic valve replacement (TAVR) and worldwide interest in its implantation, TAVR valve explantation has not been well described.<h4>Methods</h4>We retrospectively reviewed 1442 consecutive patients who underwent a TAVR procedure between 2011 and 2019, in which TAVR explantation was performed in 15 patients (1.0%). In addition, 2 patients from outside institutions also underwent TAVR explantation at our institution. We reviewed the clinical details of these 17 patients.<h4>Results</h4>The frequency of TAVR explant increased over time from 0 to 1 during the period from 2011 to 2015 to 6 in 2019. The mean age was 73.0 ± 9.3 years. The majority of patients (88.2%) were in New York Heart Association functional class IV heart failure.2021-01-01T00:00:00Z2021 Aug2025-04-03T23:47:39.602Z2022-02-09T08:02:03.835ZS-EPMC73887263203724510.1016/j.jtcvs.2019.11.139